ArriVent BioPharma, Inc. — 8-K Filings
23 8-K filings on record
This page lists all 8-K filings submitted to the SEC by ArriVent BioPharma, Inc. (AVBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. ArriVent BioPharma, Inc. has filed 23 8-K documents with the SEC since 2021. To view all SEC filings by ArriVent BioPharma, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001104659-26-029588 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001104659-26-024112 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001104659-25-108839 | Nov 10, 2025 | — |
| 8-K | 8-K | 0001558370-25-011954 | Sep 9, 2025 | — |
| 8-K | 8-K | 0001558370-25-010974 | Aug 11, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-069169 | Jul 21, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-065386 | Jul 2, 2025 | Jul 1, 2025 |
| 8-K | FORM 8-K | 0001104659-25-061375 | Jun 23, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-061165 | Jun 20, 2025 | Jun 18, 2025 |
| 8-K | 8-K | 0001558370-25-007259 | May 12, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-039799 | Apr 28, 2025 | Apr 23, 2025 |
| 8-K | 8-K | 0001558370-25-002912 | Mar 13, 2025 | Mar 11, 2025 |
| 8-K | 8-K | 0001558370-25-002002 | Mar 3, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-004967 | Jan 22, 2025 | Jan 21, 2025 |
| 8-K | 8-K | 0001558370-24-015622 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-098059 | Sep 9, 2024 | — |
| 8-K | 8-K | 0001558370-24-012223 | Aug 14, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-068503 | Jun 5, 2024 | Jun 4, 2024 |
| 8-K | FORM 8-K | 0001104659-24-062528 | May 16, 2024 | — |
| 8-K | 8-K | 0001558370-24-007196 | May 8, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-049988 | Apr 22, 2024 | Apr 20, 2024 |
| 8-K | FORM 8-K | 0001104659-24-040532 | Mar 28, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-008228 | Jan 30, 2024 | — |